Found 15 matching trials
Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD PHASE2 This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Show More Learn More & Join Trial
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Learn More & Join Trial
Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes NA The current standard treatment for advanced Hodgkin's lymphoma 6-8 cycles o...
Show More Location
Department of Medical Oncology, Cancer Institute (WIA), Adyar
Learn More & Join Trial
FIL Study on ABVD DD-DI as Upfront Therapy in HL. PHASE3 The FIL-Rouge is a randomized, open-label, multicenter, phase III, 2-arm st...
Show More Location
I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1
Learn More & Join Trial
Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma PHASE3 The choice of a preferred first-line treatment requires balancing the desir...
Show More Location
Fondazione IRCCS Istituto Nazionale di Tumori di Milano
Learn More & Join Trial
Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma PHASE3 RATIONALE: Imaging procedures, such as fludeoxyglucose F 18 (FDG)-PET/CT sc...
Show More Location
Southampton General Hospital
Learn More & Join Trial
Prognostic Significance of ctDNA in HL N/A Specific somatic mutations using ctDNA will be analyzed in predefined subgr...
Show More Location
University Hospital Hradec Kralove
Learn More & Join Trial
HD21 for Advanced Stages PHASE3 Primary objective of the trial is to demonstrate non-inferior efficacy of s...
Show More Location
University Hospital of Cologne
Learn More & Join Trial
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Arizona Cancer Center at University Medical Center North
Learn More & Join Trial
Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma NA .This study is trying to address change of chemotherapy dosage according to...
Show More Learn More & Join Trial